Early preventive treatment can help delay onset of type 1 diabetes by two years
By
Alicia Lasek
Jun 10, 2019
In an unprecedented trial, immunotherapy has proven to be effective in delaying clinical type 1 diabetes by two or more years, according to National Institutes of Health-funded research.
Some immunotherapy drugs linked to arthritis
Jun 28, 2016
A small study of cancer patients has found those immunotherapy drugs ipilimumab and nivolumab may be at some higher-than-normal risk of developing autoimmune joint and tissue diseases, including inflammatory...